Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Trevi Therapeutics
Trevi Therapeutics
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials
Xconomy
Thu, 05/9/19 - 11:06 am
IPOs
clinical trials
Axcella Health
Cortexzyme
Milestone Pharmaceuticals
NextCure
Trevi Therapeutics
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Trevi Therapeutics to Raise Up To $74 Million in IPO
CP Wire
Mon, 04/22/19 - 10:07 am
Trevi Therapeutics
nalbuphine ER
IPOs
Trevi Therapeutics to Raise Up To $74 Million in IPO
Mon, 04/22/19 - 09:49 am
Trevi Therapeutics
nalbuphine ER
IPOs
Trevi Therapeutics jumps on the biotech IPO train
Fierce Biotech
Mon, 04/8/19 - 09:47 am
IPOs
Trevi Therapeutics
idiopathic pulmonary fibrosis
levodopa-induced dyskinesia
chronic pruritus